Provided by Tiger Trade Technology Pte. Ltd.

Harmony Biosciences Holdings, Inc.

39.64
+0.07000.18%
Post-market: 39.640.00000.00%19:30 EDT
Volume:916.73K
Turnover:36.51M
Market Cap:2.31B
PE:12.82
High:40.62
Open:39.78
Low:39.25
Close:39.57
52wk High:43.49
52wk Low:25.52
Shares:58.24M
Float Shares:52.10M
Volume Ratio:1.11
T/O Rate:1.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.09
EPS(LYR):2.71
ROE:20.46%
ROA:11.62%
PB:2.31
PE(LYR):14.63

Loading ...

Harmony Biosciences Presents Phase 3 HBS-301 Trial Data in Narcolepsy, Idiopathic Hypersomnia at European Narcolepsy Days

Reuters
·
Oct 01

Deutsche Bank Lifts Price Target on Harmony Biosciences Holdings to $42 From $39, Keeps Hold Rating

MT Newswires Live
·
Oct 01

Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)

TIPRANKS
·
Sep 26

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Oruka Therapeutics (ORKA) and Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Sep 24

Harmony Biosciences CMO Budur Kumar Disposes of USD 1,656,098.48 in Common Shares

Reuters
·
Sep 19

Harmony Biosciences CMO Budur Kumar Disposes of USD 1.43 Million in Common Shares

Reuters
·
Sep 10

Harmony Biosciences to Join Cantor Global Healthcare Conference Fireside Chat

Reuters
·
Aug 27

Harmony Biosciences Price Target Announced at $60.00/Share by Wolfe Research

Dow Jones
·
Aug 26

Harmony Biosciences: Strengthening Core Business and Pipeline Support Unchanged $55 Price Target and Buy Rating

TIPRANKS
·
Aug 12

Praxis Precision Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 06

Harmony Biosciences is Maintained at Hold by Truist Securities

Dow Jones
·
Aug 06

UBS Reaffirms Their Hold Rating on Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Aug 05

Harmony Biosciences Says New Data Supports Neurology Pipeline

Benzinga Earnings
·
Aug 05

Harmony Biosciences price target raised to $30 from $28 at BofA

TIPRANKS
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Lemaitre Vascular (LMAT) and Harmony Biosciences Holdings (HRMY)

TIPRANKS
·
Aug 05

Ultragenyx Q2 Revenue Rises 28% to Record High, Net Loss Narrows

Reuters
·
Aug 05

Rigel Pharmaceuticals Q2 Revenue Rises on Strong Product Demand

Reuters
·
Aug 05

Harmony Biosciences Shares Rise After Q2 Earnings, Product Revenue Increase

MT Newswires Live
·
Aug 04

Harmony Biosciences Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 04

Harmony Biosciences Q2 WAKIX Revenue Beats on Patient Growth

Reuters
·
Aug 04